Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA621983Chairman & Chief Executive Officer
Mark A. Goldberg, MD561997President & Chief Operating Officer
Emma Reeve562014Chief Financial Officer & Vice President
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA651986Independent Director
Patrick J. Fortune PhD, MBA701996Independent Director
Richard L. Love732002Independent Director
Ellen M. Zane652006Independent Director
Eduard Enrico Holdener, MD712008Independent Director
May-Kin Ho, PhD642015Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 50,954,585 49,948,326 98.0% 0 0.0% 98.0%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,918,045 9.65%
The Vanguard Group, Inc. 4,310,745 8.46%
UBS Financial Services, Inc. 3,132,653 6.15%
Morgan Stanley & Co. LLC 2,584,111 5.07%
Fisher Asset Management LLC 2,244,444 4.40%
Hound Partners LLC 2,116,004 4.15%
SSgA Funds Management, Inc. 1,638,790 3.22%
Wellington Management Co. LLP 1,136,930 2.23%
Aberdeen Asset Managers Ltd. 1,075,841 2.11%
ClearBridge Investments LLC 1,018,554 2.00%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..-4.06%3 213
INCYTE CORPORATION38.91%28 388
QUINTILES IMS HOLDINGS..3.48%18 909
LONZA GROUP AG3.18%10 797
CELLTRION, INC.--.--%9 883
ALKERMES PLC7.50%9 115
SEATTLE GENETICS, INC.22.17%9 058
QIAGEN NV-1.16%6 639
UNITED THERAPEUTICS CO..-3.26%6 239
IONIS PHARMACEUTICALS ..-19.32%4 775
ALNYLAM PHARMACEUTICAL..39.10%4 546
ICON PLC7.34%4 402
ACADIA PHARMACEUTICALS..24.34%4 354
CHARLES RIVER LABORATO..17.38%4 237
GALAPAGOS32.70%4 023
PRA HEALTH SCIENCES IN..17.80%4 003
BIO-TECHNE CORP-2.79%3 730
NEKTAR THERAPEUTICS97.23%3 723
BB BIOTECH AG-0.82%3 101
IRONWOOD PHARMACEUTICA..16.09%2 624
EXACT SCIENCES CORPORA..74.70%2 581
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Harvard T.H. Chan School of Public Health
MedAptus, Inc.
Molecular Profiling Institute, Inc.
Tufts University
Applied Microarrays, Inc.
Jobs for Massachusetts, Inc.
PHT Technologies, Inc.
Caris Molecular Profiling Institute, Inc.
The Leukemia & Lymphoma Society, Inc.
TVP Management Co. LLC
The Floating Hospital, Inc.
Center For Private Equity & Entrepreneurship
Boston Millennia Partners III LP
George Washington University
Tufts University School of Medicine
CardioMEMS, Inc.
Epigenesis Pharmaceuticals LLC
Ascalon International, Inc.
Sapphire Therapeutics, Inc.
Syndevrx, Inc.
University of Wisconsin Foundation
PMed Management LLC
University of Illinois
Translational Accelerator LLC
Sun Mountain Capital LLC
Minuteman Health, Inc.
Cleveland Clinic Innovations
Ascalon Pharmaceuticals
Press Ganey Associates, Inc.
CerRx, Inc.
Agnovos Healthcare LLC
Cancer Prevention Pharmaceuticals Inc
PAREXEL International Ltd.
The Aaron Diamond AIDS Research Center
Swiss Cancer Foundation
New England Healthcare Institute
MedTrust Online LLC
Viridian Global Logistics, Inc.
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2017 People , Fundamentals and Ownership